SCM

Silverarc Capital Management Portfolio holdings

AUM $489M
This Quarter Return
+11.91%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
10 Year Return
AUM
$173M
AUM Growth
+$173M
Cap. Flow
+$22.9M
Cap. Flow %
13.3%
Top 10 Hldgs %
38.32%
Holding
115
New
19
Increased
26
Reduced
33
Closed
31
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$8.6M 4.86% 61,897 +5,271 +9% +$732K
VCYT icon
2
Veracyte
VCYT
$2.39B
$8.34M 4.72% 179,548 +28,687 +19% +$1.33M
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$8.13M 4.59% 45,941 +8,188 +22% +$1.45M
MRUS icon
4
Merus
MRUS
$4.98B
$7.61M 4.3% 345,964 +25,149 +8% +$553K
AMYT
5
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$6.22M 3.52% 516,221 +59,684 +13% +$719K
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.75M 3.25% 52,469 +2,434 +5% +$267K
COGT icon
7
Cogent Biosciences
COGT
$1.69B
$5.7M 3.22% 677,900 +479,655 +242% +$4.03M
IMTX icon
8
Immatics
IMTX
$619M
$5.69M 3.22% 437,866 +148,458 +51% +$1.93M
FULC icon
9
Fulcrum Therapeutics
FULC
$351M
$5.24M 2.96% +185,691 New +$5.24M
NXTC icon
10
NextCure
NXTC
$13.5M
$4.86M 2.75% 721,302 +435,804 +153% +$2.94M
INSM icon
11
Insmed
INSM
$28.8B
$4.81M 2.72% 174,588 -2,845 -2% -$78.3K
RACB
12
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$4.66M 2.64% 473,396 -22,459 -5% -$221K
UTHR icon
13
United Therapeutics
UTHR
$13.8B
$3.91M 2.21% 21,189 +5,900 +39% +$1.09M
ITCI
14
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$3.8M 2.15% 101,890 -11,368 -10% -$424K
CERS icon
15
Cerus
CERS
$251M
$3.77M 2.13% 619,369 +600,678 +3,214% +$3.66M
IMGN
16
DELISTED
Immunogen Inc
IMGN
$3.69M 2.08% 649,919 -177,668 -21% -$1.01M
SRRA
17
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$3.58M 2.03% 163,486 +24,181 +17% +$530K
MORF
18
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$3.27M 1.85% 57,704 -46,154 -44% -$2.61M
ITOS icon
19
iTeos Therapeutics
ITOS
$3.16M 1.78% 116,931 +41,420 +55% +$1.12M
ACRS icon
20
Aclaris Therapeutics
ACRS
$209M
$3.12M 1.76% 173,327 -15,392 -8% -$277K
ARVN icon
21
Arvinas
ARVN
$568M
$3.06M 1.73% +37,249 New +$3.06M
LPTX icon
22
Leap Therapeutics
LPTX
$12M
$2.49M 1.41% +620,000 New +$2.49M
HALO icon
23
Halozyme
HALO
$8.56B
$2.45M 1.38% 60,170 -6,503 -10% -$265K
BLU
24
DELISTED
BELLUS Health Inc.
BLU
$2.24M 1.27% 365,000 +155,067 +74% +$952K
MLTX icon
25
MoonLake Immunotherapeutics
MLTX
$3.54B
$2.22M 1.26% 223,906 -10,114 -4% -$100K